Filter
1999
Filtered Results: 1999
Text search:
drug
regimens
Featured
Recommendations
206
New Publications
527
Language
Document type
No document type
1285
Guidelines
285
Studies & Reports
247
Manuals
62
Strategic & Response Plan
38
Fact sheets
35
Training Material
25
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
120
South Africa
64
Kenya
52
Global
49
Ethiopia
48
Tanzania
47
Western and Central Europe
42
Uganda
37
Nigeria
36
Zambia
34
Nepal
31
Eastern Europe
31
Rwanda
28
Africa
25
Latin America and the Carribbean
25
Malawi
24
Ghana
22
Ukraine
21
Liberia
20
Philippines
18
Bangladesh
18
Namibia
18
Myanmar / Burma
18
Asia
17
Zimbabwe
16
Cambodia
14
Sierra Leone
13
Mozambique
12
South–East Asia Region
12
Russia
12
Lesotho
11
Indonesia
11
Botswana
10
Eswatini/ Swaziland
8
Colombia
7
Thailand
7
Cameroon
7
Senegal
7
Congo, Democratic Republic of
6
Brazil
6
Albania
5
Haiti
5
Georgia
5
Tajikistan
4
Syria
4
USA
4
Venezuela
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Pakistan
4
Benin
3
China
3
Estonia
3
Germany
3
Western Pacific Region
3
Jamaica
3
Vietnam
3
Bhutan
3
South Sudan
3
Timor Leste/ East Timor
2
Burkina Faso
2
Afghanistan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Sri Lanka
2
Sudan
2
Romania
2
Iraq
2
Somalia
2
North Macedonia
1
North Korea
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Peru
1
Morocco
1
Guinea
1
Jordan
1
Saudi Arabia
1
Middle East and North Africa
1
Denmark
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
718
Clinical Guidelines
282
Public Health
86
Women & Child Health
70
Capacity Building
41
Key Resources
27
Pharmacy & Technologies
18
Toolboxes
TB
377
HIV
352
NTDs
91
AMR
78
Pharmacy
60
Mental Health
48
COVID-19
45
NCDs
45
Ebola & Marburg
29
Refugee
23
Caregiver
23
Rapid Response
16
Conflict
16
Polio
11
Disability
9
Health Financing Toolbox
7
Specific Hazards
4
Natural Hazards
4
Planetary Health
4
Malaria
4
Global Health Education
4
Cholera
3
Social Ethics
3
Zika
1
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Accessed December 2017
A practical toolkit for young people who are passionate about advancing HIV and sexual and reproductive health and rights through national advocacy in the post-2015 agenda.
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
The Panel recommendations on initial combination regimens for the antiretroviral therapy (ART)-naive, HIV-infected patients.
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
International Journal of Drug Policy 24 (2013) e91-98
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
